|
US4343782A
(en)
*
|
1978-04-20 |
1982-08-10 |
Shapiro Howard M |
Cytological assay procedure
|
|
US4658019A
(en)
*
|
1979-04-26 |
1987-04-14 |
Ortho Pharmaceutical Corporation |
Complement-fixing monoclonal antibody to human T cells
|
|
JPS6045849B2
(ja)
*
|
1980-08-25 |
1985-10-12 |
林原 健 |
ヒトエリトロポエチンの製造方法
|
|
KR850004274A
(ko)
*
|
1983-12-13 |
1985-07-11 |
원본미기재 |
에리트로포이에틴의 제조방법
|
|
NZ210501A
(en)
*
|
1983-12-13 |
1991-08-27 |
Kirin Amgen Inc |
Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
|
|
US4703008A
(en)
*
|
1983-12-13 |
1987-10-27 |
Kiren-Amgen, Inc. |
DNA sequences encoding erythropoietin
|
|
JPS6197229A
(ja)
*
|
1984-10-18 |
1986-05-15 |
Chugai Pharmaceut Co Ltd |
安定なエリトロポエチン製剤
|
|
US4835260A
(en)
*
|
1987-03-20 |
1989-05-30 |
Genetics Institute, Inc. |
Erythropoietin composition
|
|
DE3729863A1
(de)
*
|
1987-09-05 |
1989-03-16 |
Boehringer Mannheim Gmbh |
Stabilisierte erythropoietin-lyophilisate
|
|
WO1990008822A1
(en)
*
|
1989-02-03 |
1990-08-09 |
Genetics Institute, Inc. |
Erythropoietin receptor
|
|
DE3923963A1
(de)
*
|
1989-07-20 |
1991-01-31 |
Behringwerke Ag |
Muteine des menschlichen erythropoetins, ihre herstellung und ihre verwendung
|
|
US5194596A
(en)
*
|
1989-07-27 |
1993-03-16 |
California Biotechnology Inc. |
Production of vascular endothelial cell growth factor
|
|
US5350836A
(en)
*
|
1989-10-12 |
1994-09-27 |
Ohio University |
Growth hormone antagonists
|
|
KR100221066B1
(ko)
|
1989-10-13 |
1999-10-01 |
스튜어트 엘.왓트 |
에리트로포이에틴 유사체와 그를 포함하는 제약학적 조성물
|
|
US5856298A
(en)
*
|
1989-10-13 |
1999-01-05 |
Amgen Inc. |
Erythropoietin isoforms
|
|
US5292654A
(en)
*
|
1990-12-13 |
1994-03-08 |
Whitehead Institute For Biomedical Research |
Mutant EPO receptor and uses therefor
|
|
ATE157269T1
(de)
*
|
1990-12-17 |
1997-09-15 |
Cardiovascular Imaging Systems |
Vaskularer katheter mit einem ein niedriges profil aufweisenden distalen ende
|
|
US5416071A
(en)
*
|
1991-03-12 |
1995-05-16 |
Takeda Chemical Industries, Ltd. |
Water-soluble composition for sustained-release containing epo and hyaluronic acid
|
|
US5750376A
(en)
*
|
1991-07-08 |
1998-05-12 |
Neurospheres Holdings Ltd. |
In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny
|
|
US5625035A
(en)
*
|
1992-06-05 |
1997-04-29 |
The Regents, University Of California |
Erythropoietin binding protein from mammalian serum
|
|
US6153407A
(en)
|
1992-07-28 |
2000-11-28 |
Beth Israel Deaconess Medical Center |
Erythropoietin DNA having modified 5' and 3' sequences and its use to prepare EPO therapeutics
|
|
US5614184A
(en)
|
1992-07-28 |
1997-03-25 |
New England Deaconess Hospital |
Recombinant human erythropoietin mutants and therapeutic methods employing them
|
|
US5661125A
(en)
*
|
1992-08-06 |
1997-08-26 |
Amgen, Inc. |
Stable and preserved erythropoietin compositions
|
|
DE4228839A1
(de)
|
1992-08-29 |
1994-03-03 |
Behringwerke Ag |
Verfahren zum Nachweis und zur Bestimmung von Mediatoren
|
|
US5354934A
(en)
*
|
1993-02-04 |
1994-10-11 |
Amgen Inc. |
Pulmonary administration of erythropoietin
|
|
US6071970A
(en)
*
|
1993-02-08 |
2000-06-06 |
Nps Pharmaceuticals, Inc. |
Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
|
|
KR960701650A
(ko)
*
|
1993-04-29 |
1996-03-28 |
찰스 엠. 브룩 |
에리트로포이에틴 유사체 조성물 및 방법(Eythropoietin analog compositions and methods)
|
|
US5700909A
(en)
*
|
1993-07-30 |
1997-12-23 |
The Regents Of The University Of California |
Prosaposin and cytokine-derived peptides
|
|
US5571787A
(en)
*
|
1993-07-30 |
1996-11-05 |
Myelos Corporation |
Prosaposin as a neurotrophic factor
|
|
ATE323771T1
(de)
*
|
1993-08-16 |
2006-05-15 |
Jong Y Lee |
Fragment des menschlichen erythropoietinrezeptors und antikörper dagegen
|
|
ZA946122B
(en)
|
1993-08-17 |
1995-03-20 |
Amgen Inc |
Erythropoietin analogs
|
|
US5859001A
(en)
*
|
1996-01-11 |
1999-01-12 |
University Of Florida Research Foundation, Inc. |
Neuroprotective effects of polycyclic phenolic compounds
|
|
US5773569A
(en)
*
|
1993-11-19 |
1998-06-30 |
Affymax Technologies N.V. |
Compounds and peptides that bind to the erythropoietin receptor
|
|
US5830851A
(en)
*
|
1993-11-19 |
1998-11-03 |
Affymax Technologies N.V. |
Methods of administering peptides that bind to the erythropoietin receptor
|
|
US5635388A
(en)
|
1994-04-04 |
1997-06-03 |
Genentech, Inc. |
Agonist antibodies against the flk2/flt3 receptor and uses thereof
|
|
US5604198A
(en)
*
|
1994-05-12 |
1997-02-18 |
Poduslo; Joseph F. |
Method to enhance permeability of the blood/brain blood/nerve barriers to therapeutic agents
|
|
US5763198A
(en)
*
|
1994-07-22 |
1998-06-09 |
Sugen, Inc. |
Screening assays for compounds
|
|
US5767078A
(en)
*
|
1995-06-07 |
1998-06-16 |
Johnson; Dana L. |
Agonist peptide dimers
|
|
US6121246A
(en)
*
|
1995-10-20 |
2000-09-19 |
St. Elizabeth's Medical Center Of Boston, Inc. |
Method for treating ischemic tissue
|
|
AUPN780096A0
(en)
*
|
1996-01-30 |
1996-02-22 |
Medvet Science Pty. Ltd. |
Cytokine antagonists and agonists
|
|
US5835382A
(en)
*
|
1996-04-26 |
1998-11-10 |
The Scripps Research Institute |
Small molecule mimetics of erythropoietin
|
|
US20020052309A1
(en)
*
|
1996-09-11 |
2002-05-02 |
Athanasius A. Anagnostou |
Method of treating endothelial injury
|
|
DE69823046T2
(de)
*
|
1997-01-16 |
2005-03-31 |
Neose Technologies, Inc. |
Praktische in vitro sialylierung von rekombinanten glykpproteinen
|
|
EP0885613A1
(de)
|
1997-06-21 |
1998-12-23 |
Roche Diagnostics GmbH |
Verwendung von modifizierten Hämoglobinen zur Behandlung von Anämien und Kombinationspräparate umfassend Erythropoietin und modifiziertes Hämoglobin
|
|
US6242570B1
(en)
*
|
1997-07-10 |
2001-06-05 |
Beth Israel Deaconess Medical Center |
Production and use of recombinant protein multimers with increased biological activity
|
|
US6548296B1
(en)
*
|
1997-07-23 |
2003-04-15 |
Roche Diagnostics Gmbh |
Methods for identifying human cell lines useful for endogenous gene activation, isolated human lines identified thereby, and uses thereof
|
|
US6165783A
(en)
*
|
1997-10-24 |
2000-12-26 |
Neuro Spheres Holdings Ltd. |
Erythropoietin-mediated neurogenesis
|
|
AU2051899A
(en)
*
|
1997-12-03 |
1999-06-16 |
Roche Diagnostics Gmbh |
Method for preparing polypeptides with appropriate glycosilation
|
|
US6274158B1
(en)
*
|
1998-02-04 |
2001-08-14 |
Veronica L. Zaharia Czeizler |
Treatment with recombinant human erythropoietin of bleeding in patients with normal and abnormal hemostasis
|
|
DE69825137T2
(de)
|
1998-02-23 |
2005-07-21 |
Cilag Ag International |
Liposomale Erythropoietin-Dispersion
|
|
US6291661B1
(en)
*
|
1998-07-02 |
2001-09-18 |
Immunex Corporation |
flt3-L mutants and method of use
|
|
US6103526A
(en)
*
|
1998-10-08 |
2000-08-15 |
Protein Sciences Corporation |
Spodoptera frugiperda single cell suspension cell line in serum-free media, methods of producing and using
|
|
DE19857609A1
(de)
|
1998-12-14 |
2000-06-15 |
Hannelore Ehrenreich |
Verwendung von Erythropoietin zur Behandlung von cerebralen Ischämien des Menschen
|
|
US6368453B1
(en)
*
|
1999-03-18 |
2002-04-09 |
Andritz Inc. |
Chip feeding to a comminuted cellulosic fibrous material treatment vessel
|
|
US7309687B1
(en)
|
1999-04-13 |
2007-12-18 |
The Kenneth S. Warren Institute, Inc. |
Methods for treatment and prevention of neuromuscular and muscular conditions by peripherally administered erythropoietin
|
|
US7345019B1
(en)
*
|
1999-04-13 |
2008-03-18 |
The Kenneth S. Warren Institute, Inc. |
Modulation of excitable tissue function by peripherally administered erythropoietin
|
|
PL352223A1
(en)
*
|
1999-04-13 |
2003-08-11 |
Kenneth S Warren Inst |
Modulation of excitable tissue function by peripherally administered erythropoietin
|
|
US8236561B2
(en)
*
|
1999-04-15 |
2012-08-07 |
Crucell Holland B.V. |
Efficient production of IgA in recombinant mammalian cells
|
|
US6855544B1
(en)
|
1999-04-15 |
2005-02-15 |
Crucell Holland B.V. |
Recombinant protein production in a human cell
|
|
US20050164386A1
(en)
*
|
1999-04-15 |
2005-07-28 |
Uytdehaag Alphonsus G. |
Overexpression of enzymes involved in post-translational protein modifications in human cells
|
|
US20050170463A1
(en)
*
|
1999-04-15 |
2005-08-04 |
Abraham Bout |
Recombinant protein production in permanent amniocytic cells that comprise nucleic acid encoding adenovirus E1A and E1B proteins
|
|
US7297680B2
(en)
|
1999-04-15 |
2007-11-20 |
Crucell Holland B.V. |
Compositions of erythropoietin isoforms comprising Lewis-X structures and high sialic acid content
|
|
US20060099685A1
(en)
*
|
1999-04-15 |
2006-05-11 |
Yallop Christopher A |
Recombinant expression of factor VIII in human cells
|
|
CA2372782A1
(en)
*
|
1999-05-11 |
2000-11-16 |
Wing Cheung |
Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration
|
|
CZ299516B6
(cs)
|
1999-07-02 |
2008-08-20 |
F. Hoffmann-La Roche Ag |
Konjugát erythropoetinového glykoproteinu, zpusobjeho výroby a použití a farmaceutická kompozice sjeho obsahem
|
|
JO2291B1
(en)
*
|
1999-07-02 |
2005-09-12 |
اف . هوفمان لاروش ايه جي |
Erythropoietin derivatives
|
|
US20030118547A1
(en)
*
|
2000-01-27 |
2003-06-26 |
Vandenberg Grant William |
Composition for intestinal delivery
|
|
US6586398B1
(en)
*
|
2000-04-07 |
2003-07-01 |
Amgen, Inc. |
Chemically modified novel erythropoietin stimulating protein compositions and methods
|
|
US20020061849A1
(en)
*
|
2000-05-02 |
2002-05-23 |
Soren Nielsen |
Methods for treatment of diseases associated with inflammation under non-ischemic conditions
|
|
NZ522320A
(en)
*
|
2000-05-12 |
2007-03-30 |
Neose Technologies Inc |
In vitro modification of glycosylation patterns of recombinant glycopeptides
|
|
US7087224B2
(en)
*
|
2000-10-31 |
2006-08-08 |
Amgen Inc. |
Method of treating anemia by administering IL-1ra
|
|
KR100401296B1
(ko)
*
|
2000-12-27 |
2003-10-11 |
드림바이오젠 주식회사 |
수식물질에 의해 수식된 단백질 변이체 및 이것의 제조방법
|
|
US6531121B2
(en)
*
|
2000-12-29 |
2003-03-11 |
The Kenneth S. Warren Institute, Inc. |
Protection and enhancement of erythropoietin-responsive cells, tissues and organs
|
|
US20030072737A1
(en)
*
|
2000-12-29 |
2003-04-17 |
Michael Brines |
Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
|
|
US7767643B2
(en)
*
|
2000-12-29 |
2010-08-03 |
The Kenneth S. Warren Institute, Inc. |
Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs
|
|
PA8536201A1
(es)
*
|
2000-12-29 |
2002-08-29 |
Kenneth S Warren Inst Inc |
Protección y mejoramiento de células, tejidos y órganos que responden a la eritropoyetina
|
|
US7300916B2
(en)
|
2001-02-27 |
2007-11-27 |
Yoshiko Yasuda |
Preventives/remedies for thickened scar, keloid or chronic arthritic diseases
|
|
FR2823220B1
(fr)
|
2001-04-04 |
2003-12-12 |
Genodyssee |
Nouveaux polynucleotides et polypeptides de l'erythropoietine (epo)
|
|
DE60232870D1
(de)
*
|
2001-04-04 |
2009-08-20 |
Genodyssee |
Neue polynukleotide und polypeptide des erythropoietingens
|
|
US6930086B2
(en)
*
|
2001-09-25 |
2005-08-16 |
Hoffmann-La Roche Inc. |
Diglycosylated erythropoietin
|
|
ATE542904T1
(de)
|
2001-10-29 |
2012-02-15 |
Crucell Holland Bv |
Verfahren und mittel zur herstellung von proteinen mit vorbestimmten posttranslationalen modifikationen
|
|
US6784154B2
(en)
*
|
2001-11-01 |
2004-08-31 |
University Of Utah Research Foundation |
Method of use of erythropoietin to treat ischemic acute renal failure
|
|
KR100467750B1
(ko)
*
|
2001-11-29 |
2005-01-24 |
씨제이 주식회사 |
생체내 에리스로포이에틴 활성이 증진된 융합단백질
|
|
KR100467751B1
(ko)
*
|
2001-12-03 |
2005-01-24 |
씨제이 주식회사 |
생체내 에리스로포이에틴 활성이 증진된 융합단백질
|
|
KR100979025B1
(ko)
*
|
2001-12-07 |
2010-08-30 |
크루셀 홀란드 비.브이. |
바이러스, 바이러스 단리물 및 백신의 생산
|
|
AU2003232122A1
(en)
*
|
2002-05-13 |
2003-11-11 |
Technion Entrepreneurial Incubator Company Ltd. |
Ctp-extended erythropoietin
|
|
US20060135854A9
(en)
*
|
2002-05-16 |
2006-06-22 |
Sleepex Systems, Inc. |
Sleep study software architecture
|
|
US7300915B2
(en)
|
2002-06-05 |
2007-11-27 |
The Regents Of The University Of California |
Use of erythropoietin and erythropoietin mimetics for the treatment of neuropathic pain
|
|
CA2491567A1
(en)
*
|
2002-07-01 |
2004-01-08 |
The Kenneth S. Warren Institute, Inc. |
Recombinant tissue protective cytokines and encoding nucleic acids thereof for protection, restoration, and enhancement of responsive cells, tissues, and organs
|
|
US20050176627A1
(en)
*
|
2002-09-09 |
2005-08-11 |
Anthony Cerami |
Long acting erythropoietins that maintain tissue protective activity of endogenous erythropoietin
|
|
US20040091961A1
(en)
*
|
2002-11-08 |
2004-05-13 |
Evans Glen A. |
Enhanced variants of erythropoietin and methods of use
|
|
JP2006521405A
(ja)
*
|
2003-03-27 |
2006-09-21 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
発作回復におけるエリトロポイエチンの使用
|
|
US20060216757A1
(en)
*
|
2003-04-25 |
2006-09-28 |
The Kenneth S. Warren Institute, Inc. |
Tissue protective cytokine receptor complex, assays for identifying tissue protective compounds and uses thereof
|
|
US7718363B2
(en)
*
|
2003-04-25 |
2010-05-18 |
The Kenneth S. Warren Institute, Inc. |
Tissue protective cytokine receptor complex and assays for identifying tissue protective compounds
|
|
EP1633305A2
(en)
*
|
2003-05-19 |
2006-03-15 |
The Kenneth S. Warren Institute, Inc. |
Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs with an extended therapeutic window
|
|
KR20070008519A
(ko)
*
|
2003-09-29 |
2007-01-17 |
워렌 파마슈티칼즈 인코포레이티드 |
패혈증 및 유착 형성의 치료 및 예방용 조직 보호성사이토카인
|
|
CA2579813A1
(en)
|
2004-07-02 |
2006-02-09 |
The Kenneth S. Warren Institute, Inc. |
Method of producing fully carbamylated erythropoietin
|
|
US20060135754A1
(en)
|
2004-07-07 |
2006-06-22 |
H. Lundbeck A/S |
Novel carbamylated EPO and method for its production
|
|
WO2006129755A1
(ja)
|
2005-06-01 |
2006-12-07 |
Niigata Tlo Corporation |
Epo誘導体含有血液関連疾患治療剤
|
|
PT2371855E
(pt)
*
|
2005-08-05 |
2015-11-03 |
Araim Pharmaceuticals Inc |
Péptidos protetores de tecidos e suas utilizações
|
|
KR100753979B1
(ko)
*
|
2005-09-07 |
2007-08-31 |
삼성전자주식회사 |
Ｄｎａ 검출 장치
|
|
US7642078B2
(en)
|
2005-12-28 |
2010-01-05 |
Crucell Holland B.V. |
Methods to obtain recombinant proteins with increased sialylation from cells that express adenovirus E1A protein, and proteins obtained thereby
|